Skip to content

Clinical trials

Completed Thromboembolism trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Status: Completed Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20061
20081
20091
20121
20131
20141
20201
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Beijing Chao Yang Hospital3
Boehringer Ingelheim2
Beijing Tiantan Hospital1
Beijing Tsinghua Chang Gung Hospital1
Daiichi Sankyo1
GlaxoSmithKline1
Wuhan Asia Heart Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism13
Pulmonary Embolism5
Thrombosis3
Venous Thromboembolism2
Venous Thrombosis2
Atrial Fibrillation1
Heart Valve Diseases1
Ischemic Attack, Transient1
Stroke1
Vascular Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.